Oklahoma 2024 Regular Session

Oklahoma House Bill HB2787

Introduced
2/6/23  
Refer
2/7/23  
Report Pass
2/16/23  
Engrossed
3/27/23  
Refer
3/30/23  

Caption

Stem cell research; reporting system; certain information collection and duties of the State Department of Health; effective date.

Impact

The bill, if enacted, will amend existing statutes related to stem cell research, specifically the Advancement in Stem Cell Cures and Therapies Act. The new regulations will prevent restrictions on public funding for approved stem cell research initiatives and prohibit any governmental actions that would discourage such research. This is intended to facilitate research efforts in areas that could lead to significant advancements in treating human diseases and improving health outcomes.

Summary

House Bill 2787 focuses on advancing stem cell research in Oklahoma by specifying regulations and establishing reporting requirements for research conducted with adult and umbilical cord stem cells. The bill defines a 'human embryo' and restricts research involving human embryos produced after a specific date to ensure ethical guidelines are followed. It aims to ensure that such research is conducted safely and ethically while providing the necessary oversight through the State Department of Health, which will establish a tracking system for these activities.

Sentiment

Generally, the sentiment surrounding HB 2787 appears to be positive among legislators who support advances in medical research and innovation. They argue that enhancing the research framework for stem cell therapies could lead to better medical treatments. Conversely, concerns may arise surrounding ethical implications and the proper use of stem cells, particularly regarding the definition and treatment of human embryos, which may create contention among certain groups or individuals opposed to stem cell research.

Contention

The major points of contention stem primarily from differing views on the ethical implications of stem cell research. Some stakeholders could potentially raise objections to any research that involves embryo definitions or restrictions, perceiving these as constraints against personal or institutional philosophies regarding the moral status of embryos. As the bill progresses, discussions may delve deeper into balancing scientific advancement with ethical considerations.

Companion Bills

OK HB2787

Carry Over Stem cell research; reporting system; certain information collection and duties of the State Department of Health; effective date.

Previously Filed As

OK HB2948

Assisted reproductive technology; terms; reporting requirements; Oklahoma State Department of Health; effective date.

OK SB1214

stem cells; birth tissue; therapy

OK H1617

Stem Cell Therapy

OK HB5160

Stem Cell Therapeutic and Research Reauthorization Act of 2025

OK HB1617

Stem Cell Therapy :

OK S1768

Stem Cell Therapy

OK SB115

Department of Justice collection and reporting of certain criminal case data. (FE)

OK AB75

Department of Justice collection and reporting of certain criminal case data. (FE)

OK SB4109

Stem Cell Therapeutic and Research Reauthorization Act of 2026

OK S07664

Requires the collection of certain demographic information by state agencies, boards, departments and commissions.

Similar Bills

HI SB1204

Relating To The University Of Hawaii.

HI SB1204

Relating To The University Of Hawaii.

CA AB1103

Controlled substances: research.

HI SB2657

Relating To Alzheimer's Disease And Related Dementias Research.

CA SB829

California Institute for Scientific Research: CalRx Initiative: vaccines.

HI HB1597

Relating To Alzheimer's Disease And Related Dementias Research.

NJ A4665

Permits certain transportation research contracts to be awarded to private research institutions of higher education and other entities.

AZ SB1722

Civil liability; fraudulent scientific research